IP Verse

Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna

Patent No. EP2611461 (titled "Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna") was filed by Glaxosmithkline on Aug 31, 2011. The application was issued on Mar 9, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONDec 9, 2022MEWBURN ELLIS
THOMANNDec 9, 2022-
WEICKMANN & WEICKMANNDec 9, 2022-
SANOFIDec 6, 2022ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2611461

GLAXOSMITHKLINE
Application Number
EP11758014A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Feb 4, 2022
Publication Date
Mar 9, 2022
External Links
Slate, Register , Google Patents